Anti-FCRL2 monoclonal antibody

Pre-made anti-FCRL2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to FCRL2/FCRL2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0840-Ab-1/ GM-Tg-hg-IP0840-Ab-2Anti-Human FCRL2 monoclonal antibodyHuman
GM-Tg-rg-IP0840-Ab-1/ GM-Tg-rg-IP0840-Ab-2Anti-Rat FCRL2 monoclonal antibodyRat
GM-Tg-mg-IP0840-Ab-1/ GM-Tg-mg-IP0840-Ab-2Anti-Mouse FCRL2 monoclonal antibodyMouse
GM-Tg-cynog-IP0840-Ab-1/ GM-Tg-cynog-IP0840-Ab-2Anti-Cynomolgus/ Rhesus macaque FCRL2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0840-Ab-1/ GM-Tg-felg-IP0840-Ab-2Anti-Feline FCRL2 monoclonal antibodyFeline
GM-Tg-cang-IP0840-Ab-1/ GM-Tg-cang-IP0840-Ab-2Anti-Canine FCRL2 monoclonal antibodyCanine
GM-Tg-bovg-IP0840-Ab-1/ GM-Tg-bovg-IP0840-Ab-2Anti-Bovine FCRL2 monoclonal antibodyBovine
GM-Tg-equg-IP0840-Ab-1/ GM-Tg-equg-IP0840-Ab-2Anti-Equine FCRL2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0840-Ab-1/ GM-Tg-hg-IP0840-Ab-2; GM-Tg-rg-IP0840-Ab-1/ GM-Tg-rg-IP0840-Ab-2;
GM-Tg-mg-IP0840-Ab-1/ GM-Tg-mg-IP0840-Ab-2; GM-Tg-cynog-IP0840-Ab-1/ GM-Tg-cynog-IP0840-Ab-2;
GM-Tg-felg-IP0840-Ab-1/ GM-Tg-felg-IP0840-Ab-2; GM-Tg-cang-IP0840-Ab-1/ GM-Tg-cang-IP0840-Ab-2;
GM-Tg-bovg-IP0840-Ab-1/ GM-Tg-bovg-IP0840-Ab-2; GM-Tg-equg-IP0840-Ab-1/ GM-Tg-equg-IP0840-Ab-2
Products NameAnti-FCRL2 monoclonal antibody
Formatmab
Target NameFCRL2
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-FCRL2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0840-Ag-1Recombinant multi-species FCRL2/ CD307b/ FCRH2 protein


    Target information

    Target IDGM-IP0840
    Target NameFCRL2
    Gene ID79368,718824,612038,102900134
    Gene Symbol and SynonymsCD307b,FCRH2,FCRL2,IFGP4,IRTA4,SPAP1,SPAP1A,SPAP1B,SPAP1C
    Uniprot AccessionQ96LA5
    Uniprot Entry NameFCRL2_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000132704
    Target ClassificationN/A

    The target: FCRL2, gene name: FCRL2, also named as CD307b, FCRH2, IFGP4, IRTA4, SPAP1, SPAP1A, SPAP1B, SPAP1C. This gene encodes a member of the immunoglobulin receptor superfamily and is one of several Fc receptor-like glycoproteins clustered on the long arm of chromosome 1. The encoded protein has four extracellular C2-type immunoglobulin domains, a transmembrane domain and a cytoplasmic domain that contains one immunoreceptor-tyrosine activation motif and two immunoreceptor-tyrosine inhibitory motifs. This protein may be a prognostic marker for chronic lymphocytic leukemia. Alternatively spliced transcript variants have been described, but their biological validity has not been determined. [provided by RefSeq, Apr 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.